News from all angles
(MedPage Today) -- Use of GLP-1 receptor agonists in breast cancer patients was linked to lower mortality and recurrence risk in a retrospective study, but experts are questioning the quality of the …
Redirecting to MedPage Today in 3 seconds...
Share this story with your network